A novel role of low molecular weight hyaluronan in breast cancer metastasis

FASEB Journal

Volumn 29, Issue 4, 2015, Pages 1290-1298

  Wu, Man ^a   Cao, Manlin ^a   He, Yiqing ^a   Liu, Yiwen ^a   Yang, Cuixia ^a   Du, Yan ^a   Wang, Wenjuan ^a   Gao, Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Biomarker; LMW HA; Lymphatic invasion; Mammary carcinoma; Prognosis

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; HYALURONAN SYNTHASE; HYALURONIC ACID; HYALURONIDASE; LOW MOLECULAR WEIGHT HYALURONAN; RNA; SYNTHETASE; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; GLUCURONOSYLTRANSFERASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HAS2 PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE; HYAL2 PROTEIN, HUMAN; HYALURONOGLUCOSAMINIDASE; MGEA5 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BREAST; BREAST CANCER; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER GROWTH; CANCER STAGING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VOLUME; BREAST TUMOR; CASE CONTROL STUDY; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DISEASE COURSE; GENETICS; MCF 7 CELL LINE; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; SECONDARY; TUMOR CELL LINE; UPREGULATION;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; GLUCURONOSYLTRANSFERASE; GPI-LINKED PROTEINS; HISTONE ACETYLTRANSFERASES; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MCF-7 CELLS; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84931407643     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-259978     Document Type: Article

References (42)

1. DeSantis, C., Siegel, R., Bandi, P., and Jemal, A. (2011) Breast cancer statistics, 2011. CA Cancer J. Clin. 61, 409-418
2. Veiseh, M., and Turley, E. A. (2011) Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer. Integr. Biol. 3, 304-315
3. Stern, R., Asari, A. A., and Sugahara, K. N. (2006) Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 85, 699-715
4. Slevin, M., West, D., Kumar, P., Rooney, P., and Kumar, S. (2004) Hyaluronan, angiogenesis and malignant disease. Int. J. Cancer 109, 793-794, author reply 795-796
5. Deed, R., Rooney, P., Kumar, P., Norton, J. D., Smith, J., Freemont, A. J., and Kumar, S. (1997) Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 71, 251-256
6. Slevin, M., Kumar, S., and Gaffney, J. (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J. Biol. Chem. 277, 41046-41059
7. Matou-Nasri, S., Gaffney, J., Kumar, S., and Slevin, M. (2009) Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and γ-adducin. Int. J. Oncol. 35, 761-773
8. Wu, M., Du, Y., Liu, Y., He, Y., Yang, C., Wang, W., and Gao, F. (2014) Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways. PLoS ONE 9, e92857
9. Tempel, C., Gilead, A., and Neeman, M. (2000) Hyaluronic acid as an anti-angiogenic shield in the preovulatory rat follicle. Biol. Reprod. 63, 134-140
10. Fujisaki, T., Tanaka, Y., Fujii, K., Mine, S., Saito, K., Yamada, S., Yamashita, U., Irimura, T., and Eto, S. (1999) CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res. 59, 4427-4434
11. Sugahara, K. N., Hirata, T., Hayasaka, H., Stern, R., Murai, T., and Miyasaka, M. (2006) Cancer cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J. Biol. Chem. 281, 5861-5868.
12. Voelcker, V., Gebhardt, C., Averbeck, M., Saalbach, A., Wolf, V., Weih, F., Sleeman, J., Anderegg, U., and Simon, J. (2008) Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp. Dermatol. 17, 100-107
13. Kung, C. I., Chen, C. Y., Yang, C. C., Lin, C. Y., Chen, T. H., and Wang, H. S. (2012) Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration. Oncol. Rep. 28, 1808-1814
14. Lokeshwar, V. B., Rubinowicz, D., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M., and Lokeshwar, B. L. (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J. Biol. Chem. 276, 11922-11932
15. Kumar, S., West, D. C., Ponting, J. M., and Gattamaneni, H. R. (1989) Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int. J. Cancer 44, 445-448
16. Dahl, I. M. S., and Laurent, T. C. (1988) Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer 62, 326-330
17. Fisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B., Foster, R., Gardner, B., Lerner, H., Margolese, R., Poisson, R., Shibata, H., and Volk, H. . (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52, 1551-1557
18. Al'Qteishat, A., Gaffney, J., Krupinski, J., Rubio, F., West, D., Kumar, S., Kumar, P., Mitsios, N., and Slevin, M. (2006) Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain 129, 2158-2176
19. Gao, F., Cao, M., Yang, C., He, Y., and Liu, Y. (2006) Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J. Biomed. Mater. Res. B Appl. Biomater. 78, 385-392
20. Slomiany, M. G., Dai, L., Bomar, P. A., Knackstedt, T. J., Kranc, D. A., Tolliver, L., Maria, B. L., and Toole, B. P. (2009) Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res. 69, 4992-4998
21. Mahoney, D. J., Aplin, R. T., Calabro, A., Hascall, V. C., and Day, A. J. (2001) Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length. Glycobiology 11, 1025-1033
22. Tengblad, A. (1980) Quantitative analysis of hyaluronate in nanogram amounts. Biochem. J. 185, 101-105
23. Yang, C., Cao, M., Liu, H., He, Y., Xu, J., Du, Y., Liu, Y., Wang, W., Cui, L., Hu, J., and Gao, F. (2012) The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J. Biol. Chem. 287, 43094-43107
24. Stern, M., and Stern, R. (1992) An ELISA-like assay for hyaluronidase and hyaluronidase inhibitors. Matrix 12, 397-403
25. Boyland, E., Wallace, D. M., and Williams, D. C. (1957) Enzyme activity in relation to cancer: inhibition of urinary β-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds. Br. J. Cancer 11, 578-589
26. Nykopp, T. K., Rilla, K., Tammi, M. I., Tammi, R. H., Sironen, R., Hämäläinen, K., Kosma, V. M., Heinonen, S., and Anttila, M. (2010) Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer 10, 512
27. Weiss, I., Trope, C. G., Reich, R., and Davidson, B. (2012) Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure. Int. J. Mol. Sci. 13, 12925-12938
28. Bertrand, P., Girard, N., Duval, C., d'Anjou, J., Chauzy, C., Ménard, J. F., and Delpech, B. (1997) Increased hyaluronidase levels in breast tumor metastases. Int. J. Cancer 73, 327-331
29. Afify, A. M., Stern, M., Guntenhöner, M., and Stern, R. (1993) Purification and characterization of human serum hyaluronidase. Arch. Biochem. Biophys. 305, 434-441
30. Lokeshwar, V. B., Lokeshwar, B. L., Pham, H. T., and Block, N. L. (1996) Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 56, 651-657
31. Udabage, L., Brownlee, G. R., Nilsson, S. K., and Brown, T. J. (2005) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp. Cell Res. 310, 205-217
32. Bertrand, P., Girard, N., Delpech, B., Duval, C., d'Anjou, J., and Dauce, J. P. (1992) Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int. J. Cancer 52, 1-6
33. Delpech, B., Chevallier, B., Reinhardt, N., Julien, J. P., Duval, C., Maingonnat, C., Bastit, P., and Asselain, B. (1990) Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int. J. Cancer 46, 388-390
34. Ponting, J., Howell, A., Pye, D., and Kumar, S. (1992) Prognostic relevance of serum hyaluronan levels in patients with breast cancer. Int. J. Cancer 52, 873-876
35. Lokeshwar, V. B., Cerwinka, W. H., and Lokeshwar, B. L. (2005) HYAL1 hyaluronidase: a molecular determinant of bladder cancer growth and invasion. Cancer Res. 65, 2243-2250
36. Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., Hamaguchi, M., and Kimata, K. (2004) Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J. Biol. Chem. 279, 18679-18687
37. Adamia, S., Maxwell, C. A., and Pilarski, L. M. (2005) Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5, 3-14
38. Lokeshwar, V. B., Cerwinka, W. H., and Lokeshwar, B. L. (2005) HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res. 65, 2243-2250
39. Tan, J. X., Wang, X. Y., Li, H. Y., Su, X. L., Wang, L., Ran, L., Zheng, K., and Ren, G. S. (2011) HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Int. J. Cancer 128, 1303-1315
40. Stern, R. (2003) Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 13, 105R-115R
41. Udabage, L., Brownlee, G. R., Stern, R., and Brown, T. J. (2004) Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study. Glycoconj. J. 20, 461-471
42. Rooney, P., Kumar, S., Ponting, J., and Wang, M. (1995) The role of hyaluronan in tumour neovascularization (review). Int. J. Cancer 60, 632-636